VQ Biomedical, Inc. — Form D
VQ Biomedical, Inc. of APEX, NC, a company, filed a Form D exempt-offering notice with the SEC on 2025-03-27. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-03-27
- Form: D
- Accession: 0002062029-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Investors: 21
- Date of first sale: 2024-07-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-542278
Issuer
- Name: VQ Biomedical, Inc.
- CIK: 0002062029
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 5448 APEX PEAKWAY, APEX, NC, 27502
- Phone: 9194463315
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| MARC DESHUSSES | Director | APEX, NC |
| Daniel E Estay | Director | APEX, NC |
| JOE KNIGHT | Director | APEX, NC |
| GALEN ROBERTSON | Director | APEX, NC |
| TOBIAS STRAUBE | Director | APEX, NC |
| GALEN ROBERTSON | Executive Officer | APEX, NC |
| TOBIAS STRAUBE | Executive Officer | APEX, NC |
More